Sort   by:  
 Page size 
UnknownEstimating the benefit of esketamine nasal spray versus real-world treatment on patient-reported functional remission: results from the ICEBERG study.
Not available
S-EPMC11491562 | biostudies-literature
UnknownIndirect adjusted comparison of 6-month clinical outcomes between esketamine nasal spray and other real-world polypharmacy treatment strategies for treatment resistant depression: results from the ICEBERG study.
Not available
S-EPMC10669145 | biostudies-literature
UnknownICEBERG study: an indirect adjusted comparison estimating the long-term benefit of esketamine nasal spray when compared with routine treatment of treatment resistant depression in general psychiatry.
Not available
S-EPMC10669153 | biostudies-literature
UnknownThe effect of sample size on polygenic hazard models for prostate cancer.
Not available
S-EPMC7608255 | biostudies-literature
UnknownMultiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans.
Not available
S-EPMC4572072 | biostudies-literature
UnknownA Genetic Risk Score to Personalize Prostate Cancer Screening, Applied to Population Data.
Not available
S-EPMC7483627 | biostudies-literature
UnknownPolygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts.
Not available
S-EPMC5759091 | biostudies-literature
UnknownPrediction of individual genetic risk to prostate cancer using a polygenic score.
Not available
S-EPMC7745998 | biostudies-literature
UnknownThe effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium.
Not available
S-EPMC4596899 | biostudies-literature
UnknownThe <i>CHEK2</i> Variant C.349A>G Is Associated with Prostate Cancer Risk and Carriers Share a Common Ancestor.
Not available
S-EPMC7694218 | biostudies-literature
Sort   by:  
 Page size